These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13511053)

  • 1. [Two more cases of scleroderma treated with disodium tetracemate].
    THIERS H; COLOMB D; FAYOLLE J; MOULIN G; TAINE B
    Bull Soc Fr Dermatol Syphiligr; 1957; 39(4):446-7. PubMed ID: 13511053
    [No Abstract]   [Full Text] [Related]  

  • 2. 2 New cases of scleroderma treated by disodium tetracemate.
    THIERS H; COLOMB D; FAYOLLE J; MOULIN G; TAINE B
    Lyon Med; 1958 Jan; 90(2):49-50. PubMed ID: 13515532
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recent occurrences in the therapy of a form of scleroderma: acrosclerosis].
    KAMINSKY A; KAPLAN A
    Sem Med; 1958 Aug; 113(6):261-6 passim. PubMed ID: 13602893
    [No Abstract]   [Full Text] [Related]  

  • 4. Scleroderma (acrosclerosis). I. Treatment of three cases of the non-calcific variety by Chelation (EDTA).
    RUKAVINA JG; MENDELSON C; PRICE JM; BROWN RR; JOHNSON SA
    J Invest Dermatol; 1957 Oct; 29(4):273-88. PubMed ID: 13491891
    [No Abstract]   [Full Text] [Related]  

  • 5. [Trials of generalized scleroderma therapy with disodium versenate].
    Machalski M; Wojtacha-Wencel B; Mazanek E
    Pol Tyg Lek; 1966 Mar; 21(13):467-70. PubMed ID: 4957497
    [No Abstract]   [Full Text] [Related]  

  • 6. Scleroderma (acrosclerosis). II. Tryptophan metabolism before and during treatment by Chelaton (EDTA).
    PRICE JM; BROWN RR; RUKAVINA JG; MENDELSON C; JOHNSON SA
    J Invest Dermatol; 1957 Oct; 29(4):289-98. PubMed ID: 13491892
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of scleroderma with the new chelating agent, edathamil.
    MULLER SA; BRUNSTING LA; WINKELMANN RK
    AMA Arch Derm; 1959 Aug; 80(2):187-94. PubMed ID: 13669744
    [No Abstract]   [Full Text] [Related]  

  • 8. A technique for intravenous therapy in patients with scleroderma and in apprehensive children.
    LUNDY JS
    AMA Arch Derm; 1959 Aug; 80(2):226-7. PubMed ID: 13669755
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of systemic sclerosis with disodium edta, pyridoxine and reserpine.
    Birk RE; Rupe CE
    Henry Ford Hosp Med J; 1966 Jun; 14(2):109-18. PubMed ID: 4957307
    [No Abstract]   [Full Text] [Related]  

  • 10. Scleroderma. An evaluation of treatment with disodium edetate.
    NELDNER KH; WINKELMANN RK; PERRY HO
    Arch Dermatol; 1962 Sep; 86():305-9. PubMed ID: 14478876
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of scleroderma with the disodium salt of ethylenediaminetetraacetic acid: a contribution to the toxicology of versenate. Part 1].
    HOESLI P
    Arzneimittelforschung; 1960 Feb; 10():65-74. PubMed ID: 14402320
    [No Abstract]   [Full Text] [Related]  

  • 12. [The therapy of scleroderma with the disodium salt of ethylenediamine-tetraacetic acid: a contribution to the toxicology of versenate. Part 2].
    HOESLI P
    Arzneimittelforschung; 1960 Mar; 10():177-81. PubMed ID: 14402321
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mercurial tremor; effects of calcium disodium tetracemate and BAL therapy].
    HADENGUE A; BARRE Y; MANSON J; LE BRETON R; CHARLIER J
    Arch Mal Prof; 1957; 18(5):561-4. PubMed ID: 13479187
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sclerodactyly with digital and pre-rotular calcinosis (Thibierge-Weissenbach syndrome) preceded by Renaud's syndrome; results of treatment with a chelating agent (sodium salt of edathamil)].
    NICK J; CONTAMIN F; HARL JM; MORIN P
    Bull Mem Soc Med Hop Paris; 1957 Feb 1-15; 73(4-6):169-74. PubMed ID: 13413679
    [No Abstract]   [Full Text] [Related]  

  • 15. [The therapy of scleroderma with chelating agents].
    NEJEDLY O; PIPER HG
    Hautarzt; 1960 Aug; 11():378-9. PubMed ID: 13728235
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of scleroderma by chelation].
    CORRALES H
    Rev Med Hondur; 1960; 28():84-7. PubMed ID: 13695652
    [No Abstract]   [Full Text] [Related]  

  • 17. [Follow-up examinations of patients treated with EDTA for scleroderma].
    Langhof H
    Dermatol Wochenschr; 1965 Jul; 151(30):862-4. PubMed ID: 4954170
    [No Abstract]   [Full Text] [Related]  

  • 18. An objective evaluation of the treatment of systemic scleroderma with disodium EDTA, pyridoxine and reserpine.
    Fuleihan FJ; Kurban AK; Abboud RT; Beidas-Jubran N; Farah FS
    Br J Dermatol; 1968 Mar; 80(3):184-9. PubMed ID: 4967134
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study on the treatment of diffuse scleroderma using Edtacal].
    Fedorová O
    Vnitr Lek; 1966 Jul; 12(7):682-4. PubMed ID: 4961194
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment with Chelaton Polfa of circumscribed scleroderma in a child].
    Niewiedziol B; Malczyńska E
    Pol Tyg Lek; 1968 Sep; 23(39):1487-8. PubMed ID: 4972439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.